Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Cardiothoracic Surgery|March 20, 2021
Analysis of the misdiagnosis of 8 adult cases of paragonimiasis with lung masses as the main manifestation in Xishuangbanna, YunnanQiu-Hong Shu, Yang Yang, Shu-De Li, et al.International Urology and Nephrology|February 4, 2016
Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancerShi-Liang Gui, Li-Chen Teng, Shu-Qiu Wang, et al.BMC Pulmonary Medicine|June 29, 2022
Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic valuesLian-Tao Hu, Wen-Jun Deng, Zhen-Sheng Chu, et al.Journal of Cellular Physiology|November 1, 2019
CXCL3 overexpression promotes the tumorigenic potential of uterine cervical cancer cells via the MAPK/ERK pathwayYa-Ling Qi, Yue Li, Xia-Xia Man, et al.International Urology and Nephrology|March 11, 2018
Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashionHua Xin, Yu Cao, Ming-Liang Shao, et al.The Journal of Pharmacology and Experimental Therapeutics|September 27, 2012
A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmiasLuiz Belardinelli, Gongxin Liu, Cathy Smith-Maxwell, et al.Bioorganic & Medicinal Chemistry Letters|April 16, 2016
Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazineDmitry O Koltun, Eric Q Parkhill, Elfatih Elzein, et al.Bioorganic & Medicinal Chemistry Letters|April 4, 2016
Discovery of triazolopyridinone GS-462808, a late sodium current inhibitor (Late INai) of the cardiac Nav1.5 channel with improved efficacy and potency relative to ranolazineDmitry O Koltun, Eric Q Parkhill, Elfatih Elzein, et al.Journal of Medicinal Chemistry|October 4, 2016
Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late INai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic PropertiesJeff A Zablocki, Elfatih Elzein, Xiaofen Li, et al.Pageof 3